You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 90 No. 5, NOVEMBER 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CORTICOTROPIN AND CORTISONE IN THE TREATMENT OF AGRANULOCYTOSIS AND THROMBOCYTOPENIC PURPURA

Report of Four Cases

MIKKO VIRKKUNEN, M.D.

AMA Arch Intern Med. 1952;90(5):580-586.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE BENEFICIAL effect of corticotropin (ACTH) and cortisone in drug hypersensitivities is well known,1 but only a few reports have been published on their usefulness in severe hypersensitive blood abnormalities. The efficacy of corticotropin and cortisone in agranulocytosis has been confirmed by Caldwell and co-workers2 and by McMillin.3 In the case reported by the former, treatment with cortisone was successful; the latter author described a rapid and complete remission with corticotropin therapy in a case of severe agranulocytosis. In both patients agranulocytosis resulted from sulfonamide therapy. Attempts to control thrombocytopenia with corticotropin or cortisone have given varying results. Combes and Costello4 have reported a case in which severe thrombocytopenia with purpura and mucosal hemorrhage was arrested by treatment with cortisone. In patients with idiopathic thrombocytopenic purpura remissions induced by the administration of corticotropin or cortisone have also been reported5; on the other hand, there arecases in which no improvement . . . [Full Text PDF of this Article]


Author Affiliations

HELSINKI, FINLAND

From the Medical Department of the Kivelä Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.